Loading...
Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Ubiquitylation as a Novel Pharmaceutical Target for Cystic Fibrosis
Mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene decrease the structural stability and function of the CFTR protein, resulting in cystic fibrosis. Recently, the effect of CFTR-targeting combination therapy has dramatically increased, and it is expected that add-on dru...
Saved in:
| Published in: | Pharmaceuticals (Basel) |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
MDPI
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7243099/ https://ncbi.nlm.nih.gov/pubmed/32331485 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph13040075 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|